IRVINE, Calif., Sept. 18, 2008 (GLOBE NEWSWIRE) -- SenoRx (Nasdaq:SENO) today announced that three abstracts summarizing clinical findings related to its Contura(tm) Multi-Lumen Balloon (MLB) Catheter are scheduled for presentation at upcoming conferences. One abstract will be presented at the 50th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Boston, Massachusetts, September 21-25, 2008. The other two abstracts will be presented at the 31st Annual San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Texas, December 10-14, 2008.
Following are the three abstracts to be presented:
"Initial Dosimetric Experience with the Contura(tm) Multi-Lumen Radiation Balloon Applicator" - Authors: Kim, L.; Sebastian, E.; Ghilezan, M.; Wallace, M.; and Vicini, F. - to be presented at ASTRO (9/21-25/08)
"Initial Radiation Experience Evaluating Early Tolerance and Toxicities in Patients Undergoing Accelerated Partial Breast Irradiation Using the Contura(tm) Multi-Lumen Balloon (MLB) Breast Brachytherapy Catheter" - Authors: Brown, S., McLaughlin, M.; Pope, K.; Haile, K.; Whitaker, T.; Hughes, L.; and Israel, P. - to be presented at SABCS (12/10-14/08)
"A Contura(tm) Catheter Provides Dosimetric Advantage Over a MammoSite(tm) Catheter for Accelerated Partial Breast Irradiation" - Authors: Wilder, R.; Mesa, A.; Chittenden, L.; Curcio, L.; Khanijou, R.; Eisner, M.; Ravera, J., and Tokita, K. - to be presented at SABCS (12/10-14/08)
About SenoRx
SenoRx (Nasdaq:SENO) develops, manufactures and sells minimally invasive medical devices used by breast care specialists for the diagnosis and treatment of breast cancer, including its EnCor(r) vacuum-assisted breast biopsy system and Contura(tm) MLB catheter for delivering radiation to the tissue surrounding the lumpectomy cavity following surgery for breast cancer. SenoRx's field sales organization serves over 1,000 breast diagnostic and treatment centers in the United States and Canada. In addition, SenoRx sells several of its products through distributors in more than 20 countries outside the U.S. and Canada. The company's line of breast care products includes biopsy disposables, biopsy capital equipment, diagnostic adjunct products and therapeutic disposables. SenoRx is developing additional minimally invasive products for the diagnosis and treatment of breast cancer. For more information, visit the company's website at www.senorx.com.
The SenoRx, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3605